Friday, February 27, 2009

Solostar Injection Pen Approved for Diabetes

(HealthDay News) -- Sanofi-Aventis's Apidra (insulin glulisine) Solostar injection pen has been approved to treat diabetes, the company said Thursday in a news release.

The disposable pen with rapid-acting insulin was approved for adults with type 2 diabetes and for children four years and older with type 1 diabetes.

The device requires lower injection force than competing products, the drug maker said.

More information
The FDA has additional information about Apidra, a drug first approved in 2004.

No comments:


Dr. Group's Secret to Health Kit

Dr. Group's Secret to Health Kit

[ learn more ]

Add to Cart

Dr. Group's Secret to Health Kit offers simple at-home solutions for cleansing internally and externally thereby reducing toxins, restoring the body's natural healing process, and helping you achieve true health and happiness.